Panion & BF Biotech Inc Total Liabilities
Panion & BF Biotech Inc total liabilities. Based on the latest financial reports, Panion & BF Biotech Inc (1760) has total liabilities worth NT$1.22 Billion TWD (≈ $38.52 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check 1760 asset liquidity ratio to evaluate the company's liquid asset resilience ratio.
Total Liabilities of Panion & BF Biotech Inc (2009–2024)
Total liabilities of Panion & BF Biotech Inc from 2009 to 2024. This chart illustrates how Panion & BF Biotech Inc's total liabilities have evolved over time, based on quarterly financial data.
Panion & BF Biotech Inc Competitors by Total Liabilities
The table below lists competitors of Panion & BF Biotech Inc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Chia Chang Co Ltd
TW:4942
|
Taiwan | NT$2.09 Billion |
|
Companhia Estadual de Distribuição de Energia Elétrica
SA:CEED3
|
Brazil | R$14.38 Billion |
|
Inclusio Sca
BR:INCLU
|
Belgium | €168.45 Million |
|
Smartbroker Holding AG
XETRA:SB1
|
Germany | €14.03 Million |
|
Enad Global 7 AB
ST:EG7
|
Sweden | Skr1.09 Billion |
|
AirBoss of America Corp.
TO:BOS
|
Canada | CA$171.05 Million |
|
Biosyent Inc.
V:RX
|
Canada | CA$7.88 Million |
|
Western Investment Company of Canada Limited
V:WI
|
Canada | CA$60.14 Million |
Liability Composition Analysis (2009–2024)
This chart breaks down Panion & BF Biotech Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see total assets of Panion & BF Biotech Inc.
Liquidity & Leverage Metrics
Panion & BF Biotech Inc Total Liabilities Ratios Explained
Panion & BF Biotech Inc total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.41 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.64 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.39 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Panion & BF Biotech Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Panion & BF Biotech Inc (2009–2024)
The table below shows the annual total liabilities of Panion & BF Biotech Inc from 2009 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | NT$1.29 Billion ≈ $40.51 Million |
-2.89% |
| 2023-12-31 | NT$1.32 Billion ≈ $41.72 Million |
+21.88% |
| 2022-12-31 | NT$1.09 Billion ≈ $34.23 Million |
+6.50% |
| 2021-12-31 | NT$1.02 Billion ≈ $32.14 Million |
-44.38% |
| 2020-12-31 | NT$1.83 Billion ≈ $57.78 Million |
+231.68% |
| 2019-12-31 | NT$552.94 Million ≈ $17.42 Million |
+14.15% |
| 2018-12-31 | NT$484.38 Million ≈ $15.26 Million |
+17.53% |
| 2017-12-31 | NT$412.15 Million ≈ $12.99 Million |
+7.10% |
| 2016-12-31 | NT$384.82 Million ≈ $12.12 Million |
-3.87% |
| 2015-12-31 | NT$400.33 Million ≈ $12.61 Million |
+0.80% |
| 2014-12-31 | NT$397.15 Million ≈ $12.51 Million |
+15.46% |
| 2013-12-31 | NT$343.99 Million ≈ $10.84 Million |
-46.70% |
| 2012-12-31 | NT$645.34 Million ≈ $20.33 Million |
+1.29% |
| 2011-12-31 | NT$637.11 Million ≈ $20.07 Million |
+13.75% |
| 2010-12-31 | NT$560.10 Million ≈ $17.65 Million |
+2.05% |
| 2009-12-31 | NT$548.82 Million ≈ $17.29 Million |
-- |
About Panion & BF Biotech Inc
Panion & Bf Biotech Inc., a biotechnology pharmaceutical company, provides western medicines, cosmetics, testing reagents, food and chemical products in Taiwan, the United States, China, Hong Kong, Macau, and internationally. The company offers products in the areas of antibody, respiratory, gastrointestinal, COVID-19 IVD, antigen, anti-aging, active pharmaceutical ingredients, disease treatment,… Read more